Tagworks will present the IND-enabling data of the first in class click-cleavable ADC, TGW101, targeting non-internalizing pan-carcinoma marker TAG72. The presentation is part of the session on Preclinical Profiles Leading to First-in-Human Trials and will take place on Wednesday November 5, 14.30 at World ADC USA in San Diego.

https://worldadc-usa.com/